Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Dreyling

Showing results (41-50 of 336) with videos related to

Pageof 34
Sort By:
Leukemia & Lymphoma|January 29, 2011
Chlorambucil in indolent mantle cell lymphoma--just another old drug for a new disease?Martin Dreyling, Aaron Polliack, Tamar Tadmor
Immunotherapy|July 20, 2010
Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategiesTill Seiler, Wolfgang Hiddemann, Martin Dreyling
Blood|November 3, 2018
Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!Martin Dreyling, Wolfram Klapper, Simon Rule
British Journal of Haematology|March 30, 2021
Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approachesElisabeth Silkenstedt, Kim Linton, Martin Dreyling
Blood|October 14, 2010
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic eraPatricia Pérez-Galán, Martin Dreyling, Adrian Wiestner
Clinical Advances in Hematology & Oncology : H&O|December 2, 2006
Indolent lymphomas: current and emerging treatment approachesDavid Maloney, Brad S Kahl, Martin Dreyling
Drugs|August 9, 2007
Current management of mantle cell lymphomaOliver Weigert, Michael Unterhalt, Wolfgang Hiddemann, et al.
Cancer|July 11, 2006
Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphomaOliver Weigert, Tim Illidge, Wolfgang Hiddemann, et al.
Current Opinion in Hematology|June 2, 2005
Transplantation strategies for patients with follicular lymphomaChristian Buske, Martin Dreyling, Michael Unterhalt, et al.
Leukemia & Lymphoma|April 26, 2019
Mantle cell lymphoma: therapeutic options in transplant-ineligible patientsTadeusz Robak, Piotr Smolewski, Pawel Robak, et al.
Pageof 34

Showing results (41-50 of 336) with videos related to

Sort By:
Pageof 34
Leukemia & Lymphoma|January 29, 2011
Chlorambucil in indolent mantle cell lymphoma--just another old drug for a new disease?Martin Dreyling, Aaron Polliack, Tamar Tadmor
Immunotherapy|July 20, 2010
Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategiesTill Seiler, Wolfgang Hiddemann, Martin Dreyling
Blood|November 3, 2018
Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!Martin Dreyling, Wolfram Klapper, Simon Rule
British Journal of Haematology|March 30, 2021
Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approachesElisabeth Silkenstedt, Kim Linton, Martin Dreyling
Blood|October 14, 2010
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic eraPatricia Pérez-Galán, Martin Dreyling, Adrian Wiestner
Clinical Advances in Hematology & Oncology : H&O|December 2, 2006
Indolent lymphomas: current and emerging treatment approachesDavid Maloney, Brad S Kahl, Martin Dreyling
Drugs|August 9, 2007
Current management of mantle cell lymphomaOliver Weigert, Michael Unterhalt, Wolfgang Hiddemann, et al.
Cancer|July 11, 2006
Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphomaOliver Weigert, Tim Illidge, Wolfgang Hiddemann, et al.
Current Opinion in Hematology|June 2, 2005
Transplantation strategies for patients with follicular lymphomaChristian Buske, Martin Dreyling, Michael Unterhalt, et al.
Leukemia & Lymphoma|April 26, 2019
Mantle cell lymphoma: therapeutic options in transplant-ineligible patientsTadeusz Robak, Piotr Smolewski, Pawel Robak, et al.
Pageof 34